{"id":"559200-5754","orgnr":"559200-5754","name":"DiffracTox AB","name_registered_on":"2019-03-29","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2019-03-29","business_description":"Bolaget skall driva konsultverksamhet inom biomedicin och läkemedelsutveckling, samt äga, förvalta, utveckla och exploatera patent, upplåta licensrättigheter, äga och förvalta värdepapper ävensom idka annan därmed förenlig verksamhet.","industries":[{"code":"72101","name":"Bioteknisk forskning och utveckling"}],"postal_address":{"street":"Sergeantgränd 16","care_of":"c/o Pål Stenmark","postal_code":"17743","city":"JÄRFÄLLA","country":"SE","municipality":{"code":"0123","name":"Järfälla"},"county":{"code":"01","name":"Stockholms län"}},"registered_office":{"municipality":{"code":"0123","name":"Järfälla"},"county":{"code":"01","name":"Stockholms län"}},"activity_status":"active","employee_class":{"code":"1","name":"0 anställda"},"turnover_class":{"code":"1","name":"1 - 499 tkr","year":2025},"f_tax":"registered","vat":"registered","employer":"registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2025-01-01","to":"2025-12-31","framework":"K2","signed_on":"2026-02-24","documents":{"annual_report":"/v1/documents/b437b579-a77d-4888-8479-9f36eb7ef5cb.xhtml"},"source":{"dataset":"arsredovisningar","file":"2026/09_5.zip"}},{"from":"2024-01-01","to":"2024-12-31","framework":"K2","signed_on":"2025-03-25","documents":{"annual_report":"/v1/documents/08b11eb6-c2db-4087-8bca-4205c46330e3.xhtml"},"source":{"dataset":"arsredovisningar","file":"2025/13_4.zip"}},{"from":"2023-01-01","to":"2023-12-31","framework":"K2","signed_on":"2024-05-15","documents":{"annual_report":"/v1/documents/fbd19b91-855c-42db-b6bc-dd4b0745dfda.xhtml"},"source":{"dataset":"arsredovisningar","file":"2024/20_4.zip"}},{"from":"2022-01-01","to":"2022-12-31","framework":"K2","signed_on":"2023-06-19","documents":{"annual_report":"/v1/documents/ec76ae24-3031-4872-842e-ee70ca924ce5.xhtml"},"source":{"dataset":"arsredovisningar","file":"2023/25_5.zip"}},{"from":"2021-01-01","to":"2021-12-31","framework":"K2","signed_on":"2022-02-28","documents":{"annual_report":"/v1/documents/c9ef6a81-ddde-4e67-9424-cdfa42f4039f.xhtml"},"source":{"dataset":"arsredovisningar","file":"2022/11_2.zip"}}],"latest_financials":{"from":"2025-01-01","to":"2025-12-31","scope":"company","currency":"SEK","net_sales":147000,"operating_profit":19147,"profit_after_financial_items":69452,"net_profit":178982,"total_assets":3197849,"current_assets":752222,"equity":2316517,"share_capital":50000,"unrestricted_equity":2266517,"untaxed_reserves":832000,"current_liabilities":49332,"tax_liabilities":2707,"cash":261810,"staff_costs":14136,"equity_ratio":0.93,"net_sales_growth":2.675,"source":{"annual_report":"2025-12-31","document":"/v1/documents/b437b579-a77d-4888-8479-9f36eb7ef5cb.xhtml"},"anchors":{"cash":{"text":"261 810","prefix":"Summa kassa och bank","suffix":"1 388 527"},"current_assets":{"text":"752 222"},"current_liabilities":{"text":"49 332"},"equity":{"text":"2 316 517","prefix":"kapital"},"equity_ratio":{"text":"93","prefix":"Soliditet (%)"},"net_profit":{"text":"178 982","suffix":"451"},"net_sales":{"text":"147 000","prefix":"Nettoomsättning"},"operating_profit":{"text":"19 147"},"profit_after_financial_items":{"text":"69 452"},"share_capital":{"text":"50 000","prefix":"utgång"},"staff_costs":{"text":"14 136"},"tax_liabilities":{"text":"2 707"},"total_assets":{"text":"3 197 849","prefix":"TILLGÅNGAR"},"unrestricted_equity":{"text":"2 266 517","prefix":"982"},"untaxed_reserves":{"text":"832 000","prefix":"reserver"}}},"officers":{"annual_report":"2025-12-31","signed_on":"2026-02-24","signatories":[{"name":"P*****","role":"Verkställande direktör"}]},"group":{"list":{"annual_report":"2025-12-31","signed_on":"2026-02-24","completeness":"not_listed","shares_in_group_companies":37500,"currency":"SEK","listed":0}}}